Physician profile
Daniel T Ayers
NPI 1912925520
$1,167.07
in general payments reported to CMS, 2019-2025
19 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $325 · 2023: $341 · 2024: $94.95 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.02 | 2022-2025 | |
| Merz North America, INC. | $164.32 | 2022 | |
| Galderma Laboratories, L.P. | $160.19 | 2024-2025 | Dysport |
| Allergan, INC. | $124.98 | 2021 | |
| Tris Pharma INC | $84.57 | 2022-2024 | Dyanavel Xr |
| Abbott Laboratories | $64.81 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Antares Pharma, INC. | $36.49 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Exact Sciences Corporation | $35.18 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $34.29 | 2022 | |
| Boston Scientific Corporation | $28.88 | 2024 | Varithena Administration Pack |
| Corium, LLC | $25.33 | 2023 | Azstarys |
| Bausch Health US, LLC | $24.70 | 2022 | |
| Tolmar, INC. | $24.08 | 2023 | |
| Lilly USA, LLC | $22.07 | 2022 | |
| Neos Therapeutics, LP | $20.36 | 2023 | Adzenys Xr-Odt |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $17.78 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $17.34 | 2023 | Farxiga |
| Azurity Pharmaceuticals, INC. | $17.00 | 2023 | Adthyza |
| Novo Nordisk INC | $14.68 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ayers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.